title: Spinocerebellar ataxia type 2 (SCA2) is associated with TDP-43 pathology.
authors.forename: Yasuko
authors.initials: Y
authors.lastname: Toyoshima
authors.forename: Hajime
authors.initials: H
authors.lastname: Tanaka
authors.forename: Mitsuteru
authors.initials: M
authors.lastname: Shimohata
authors.forename: Kakuhei
authors.initials: K
authors.lastname: Kimura
authors.forename: Takashi
authors.initials: T
authors.lastname: Morita
authors.forename: Akiyoshi
authors.initials: A
authors.lastname: Kakita
authors.forename: Hitoshi
authors.initials: H
authors.lastname: Takahashi
mesh_terms: D048868:Adaptor Proteins, Signal Transducing / Q000378:metabolism; D001921:Brain / Q000378:metabolism* / Q000473:pathology*; D004268:DNA-Binding Proteins / Q000378:metabolism*; D005192:Family Health; D005260:Female; D006801:Humans; D002479:Inclusion Bodies / Q000378:metabolism / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009474:Neurons / Q000473:pathology*; D010455:Peptides / Q000378:metabolism; D000071456:Sequestosome-1 Protein; D020754:Spinocerebellar Ataxias / Q000235:genetics / Q000378:metabolism / Q000473:pathology
chemical_list: D048868:Adaptor Proteins, Signal Transducing; D004268:DNA-Binding Proteins; D010455:Peptides; C099718:SQSTM1 protein, human; D000071456:Sequestosome-1 Protein; C097188:polyglutamine